Peter van Ooijen

Mr. Peter van Ooijen

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
HKHarry J. de Koning
Harry J. de Koning
CACarlijn M. van der Aalst
Carlijn M. van der Aalst
PJPim A. de Jong
Pim A. de Jong
ESErnst T. Scholten
Ernst T. Scholten
KNKristiaan Nackaerts
Kristiaan Nackaerts
MOMatthijs Oudkerk
Matthijs Oudkerk
There are limited data from randomized trials regarding whether volume-based, low-dose computed tomographic (CT) screening can reduce lung-cancer mortality among male former and current smokers.

3 December 2009 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
RKRob J. van Klaveren
Rob J. van Klaveren
MOMatthijs Oudkerk
Matthijs Oudkerk
MPMathias Prokop
Mathias Prokop
ESErnst T. Scholten
Ernst T. Scholten
KNKristiaan Nackaerts
Kristiaan Nackaerts
HKHarry J. de Koning
Harry J. de Koning
The use of multidetector computed tomography (CT) in lung-cancer screening trials involving subjects with an increased risk of lung cancer has highlighted the problem for the clinician of deciding on the best course of action when noncalcified pulmonary nodules are detected by CT. A total of 7557 participants underwent CT screening in years 1, 2, and 4 of a randomized trial of lung-cancer screening. We used software to evaluate a noncalcified nodule according to its volume or volume-doubling time. Growth was defined as an increase in volume of at least 25% between two scans. The first-round screening test was considered to be negative if the volume of a nodule was less than 50 mm3, if it was 50 to 500 mm3 but had not grown by the time of the 3-month follow-up CT, or if, in the case of those that had grown, the volume-doubling time was 400 days or more. In the first and second rounds of screening, 2.6% and 1.8% of the participants, respectively, had a positive test result. In round one, the sensitivity of the screen was 94.6% (95% confidence interval [CI], 86.5 to 98.0) and the negative predictive value 99.9% (95% CI, 99.9 to 100.0). In the 7361 subjects with a negative screening result in round one, 20 lung cancers were detected after 2 years of follow-up. Among subjects at high risk for lung cancer who were screened in three rounds of CT scanning and in whom noncalcified pulmonary nodules were evaluated according to volume and volume-doubling time, the chances of finding lung cancer 1 and 2 years after a negative first-round test were 1 in 1000 and 3 in 1000, respectively. (Current Controlled Trials number, ISRCTN63545820.)

1 February 2001 in The Lancet
Verified
Journal Article
Closed access
KNKoen Nieman
Koen Nieman
MOMatthijs Oudkerk
Matthijs Oudkerk
BRBenno J Rensing
Benno J Rensing
POPeter van Ooijen
Peter van Ooijen
AMArie Munne
Arie Munne
PFPim J de Feyter
Pim J de Feyter

1 November 2014 in The Lancet Oncology
Verified
Journal Article
Closed access
NHNanda Horeweg
Nanda Horeweg
JRJoost van Rosmalen
Joost van Rosmalen
MHMarjolein A Heuvelmans
Marjolein A Heuvelmans
CACarlijn M van der Aalst
Carlijn M van der Aalst
RVRozemarijn Vliegenthart
Rozemarijn Vliegenthart
MOMatthijs Oudkerk
Matthijs Oudkerk

17 January 2024 in Insights into Imaging
Verified
Journal Article
Open access
PDF file
BKBurak Kocak
Burak Kocak
TDTugba Akinci D'Antonoli
Tugba Akinci D'Antonoli
NMNathaniel Mercaldo
Nathaniel Mercaldo
AAAngel Alberich-Bayarri
Angel Alberich-Bayarri
BBBettina Baeßler
Bettina Baeßler
Renato CuocoloRenato Cuocolo
Renato Cuocolo
Purpose: To propose a new quality scoring tool, METhodological RadiomICs Score (METRICS), to assess and improve research quality of radiomics studies. Methods: We conducted an online modified Delphi study with a group of international experts. It was performed in three consecutive stages: Stage#1, item preparation; Stage#2, panel discussion among EuSoMII Auditing Group members to identify the items to be voted; and Stage#3, four rounds of the modified Delphi exercise by panelists to determine the items eligible for the METRICS and their weights. The consensus threshold was 75%. Based on the median ranks derived from expert panel opinion and their rank-sum based conversion to importance scores, the category and item weights were calculated. Result: In total, 59 panelists from 19 countries participated in selection and ranking of the items and categories. Final METRICS tool included 30 items within 9 categories. According to their weights, the categories were in descending order of importance: study design, imaging data, image processing and feature extraction, metrics and comparison, testing, feature processing, preparation for modeling, segmentation, and open science. A web application and a repository were developed to streamline the calculation of the METRICS score and to collect feedback from the radiomics community. Conclusion: In this work, we developed a scoring tool for assessing the methodological quality of the radiomics research, with a large international panel and a modified Delphi protocol. With its conditional format to cover methodological variations, it provides a well-constructed framework for the key methodological concepts to assess the quality of radiomic research papers. Critical relevance statement: A quality assessment tool, METhodological RadiomICs Score (METRICS), is made available by a large group of international domain experts, with transparent methodology, aiming at evaluating and improving research quality in radiomics and machine learning. Key points: • A methodological scoring tool, METRICS, was developed for assessing the quality of radiomics research, with a large international expert panel and a modified Delphi protocol. • The proposed scoring tool presents expert opinion-based importance weights of categories and items with a transparent methodology for the first time. • METRICS accounts for varying use cases, from handcrafted radiomics to entirely deep learning-based pipelines. • A web application has been developed to help with the calculation of the METRICS score (https://metricsscore.github.io/metrics/METRICS.html) and a repository created to collect feedback from the radiomics community (https://github.com/metricsscore/metrics). Graphical

1 May 2002 in The Lancet
Verified
Journal Article
Closed access
MOMatthijs Oudkerk
Matthijs Oudkerk
EBEdwin Jr van Beek
Edwin Jr van Beek
PWPiotr Wielopolski
Piotr Wielopolski
POPeter van Ooijen
Peter van Ooijen
EBElise Mj Brouwers-Kuyper
Elise Mj Brouwers-Kuyper
ABArie Berghout
Arie Berghout